Unity Biotechnology Inc

General ticker "UBX" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $19.1M

Unity Biotechnology Inc does not follow the US Stock Market performance with the rate: -33.3%.

Estimated limits based on current volatility of 2.8%: low 0.95$, high 1.00$

Factors to consider:

  • Company does not operate outside North America (retrieved using AI)
  • Current price 29.3% below estimated low
  • Earnings for 9 months up through Q3 are close to our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2023-12-31 to 2025-12-30

  • 2023-12-31 to 2024-12-30 estimated range: [1.41$, 3.93$]
  • 2024-12-30 to 2025-12-30 estimated range: [1.57$, 4.06$]

Financial Metrics affecting the UBX estimates:

  • Negative: Non-GAAP EPS, $ of -2.56 <= 0.10
  • Negative: Operating profit margin, % of -100 <= 1.03
  • Negative: Operating cash flow per share per price, % of -58.53 <= 2.35
  • Negative: negative Net income

Similar symbols

Short-term UBX quotes

Long-term UBX plot with estimates

Financial data

YTD 2021-12-31 2022-12-31 2023-12-31
Operating Revenue $4.78MM $0.24MM $0.00MM
Operating Expenses $61.45MM $57.81MM $44.67MM
Operating Income $-56.66MM $-57.57MM $-44.67MM
Non-Operating Income $-4.06MM $-2.35MM $4.81MM
Interest Expense $3.18MM $3.56MM $0.00MM
R&D Expense $38.39MM $36.86MM $20.10MM
Income(Loss) $-60.73MM $-59.93MM $-39.86MM
Profit(Loss) $-60.73MM $-59.93MM $-39.86MM
Stockholders Equity $59.57MM $66.85MM $28.40MM
Inventory $0.00MM $0.23MM $0.00MM
Assets $124.71MM $124.35MM $65.69MM
Operating Cash Flow $-45.06MM $-51.03MM $-37.09MM
Capital expenditure $0.20MM $0.10MM $0.01MM
Investing Cash Flow $39.31MM $-24.55MM $60.49MM
Financing Cash Flow $20.84MM $54.85MM $-16.34MM
Earnings Per Share* $-10.76 $-6.08 $-2.70

* EPS are Split Adjusted, recent splits may be reflected with a delay.